Home › Macular Degeneration › California
Macular Degeneration clinical trials in California
20 studies for Macular Degeneration are looking for participants at sites in California.
Cities in California
- Sacramento7 studies
- Santa Monica7 studies
- Mountain View5 studies
- San Francisco4 studies
- Bakersfield3 studies
- Concord3 studies
- Escondido3 studies
- Oxnard3 studies
- Modesto3 studies
- San Bernardino3 studies
- Pasadena3 studies
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- Stanford University School of Medicine, Palo Alto
- University of California Health - UC Davis, Sacramento
RecruitingObservational study
Ages 6 and older · All sexes · Updated Nov 13, 2026 · NCT07425574A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
- Retina-Vitreous Associates Medical Group, Beverly Hills
- Bay Area Retina Associates, Walnut Creek
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Nov 10, 2026 · NCT06659549A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Retina Vitreous Associates Medical Group, Beverly Hills
- Retina Specialists of Beverly Hills- Department of Ophthalmology, Beverly Hills
- Eye Medical Center of Fresno, Fresno
- and 20 more
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Nov 5, 2026 · NCT06541704Safety and Efficacy of AIV007 Periocular Injection in Patients With Neovascular Age-Related Macular Degeneration
- Macula and Vitreous Center, Torrance
RecruitingPhase 2
Ages 50 to 85 · All sexes · Updated Nov 4, 2026 · NCT07557121A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
- Retina Consultants of Orange County, Fullerton
- Shiley Eye Institute Jacobs Retina Center, La Jolla
- California Retina Consultants, Oxnard
- and 3 more
RecruitingPhase 2/3
Ages 60 and older · All sexes · Updated Nov 3, 2026 · NCT06635148Phase 1 Study of C.001 in Retinal Degeneration
- Retina Vision Consultants, Beverly Hills
- Palo Alto Medical Foundation, Palo Alto
- Retinal Consultants Medical Group, Sacramento
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07594236Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration
- Beverly Hills, CA, Beverly Hills
- Modesto, CA, Modesto
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Oct 9, 2026 · NCT07587515A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Global Research Management, Inc., Glendale
- Retinal Consultants Medical Group (Site 024), Modesto
- Azul Vision / California Eye Specialists Medical Group, Inc., Pasadena
- and 3 more
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Oct 2, 2026 · NCT07440225A Study in Adults With Geographic Atrophy
- California Retina Consultants, Bakersfield
- Retina-Vitreous Associates Medical Group, Beverly Hills
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- California Retina Consultants, Bakersfield
- Retina-Vitreous Associates Medical Group, Beverly Hills
- Macula and Retina Institute, Glendale
- and 4 more
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT06659445A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- Jules Stein Eye Institute, Los Angeles
- Stanford University Byers Eye Institute, Palo Alto
- Kaiser Permanente Riverside Medical Center, Riverside
RecruitingPhase 1
Ages 50 and older · All sexes · Updated Sep 3, 2026 · NCT03178149Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
- Retina Consultants San Diego, Poway
Recruiting
Ages 60 and older · All sexes · Updated Aug 26, 2026 · NCT066621624D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- California Retina Consultants, Oxnard
- Retinal Consultants Medical Group, Sacramento
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Aug 21, 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- The Retina Partners, Encino
- Northern California Retina Vitreous Associates Medical Group, Inc., Mountain View
- Orange County Retina Medical Group, Santa Ana
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Aug 6, 2026 · NCT07496567Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
- Adverum site 109, Bakersfield
- Adverum site 169, Fullerton
RecruitingPhase 2
Ages 50 and older · All sexes · Updated Aug 5, 2026 · NCT07630649Effects of Goji vs. Fiber on Macular Degeneration
- UC Davis Eye Center, Tschannen Eye Institute, Sacramento
RecruitingHealthy volunteers welcome
Ages 65 to 95 · All sexes · Updated Jul 17, 2026 · NCT06237127Village-Integrated Eye Worker Trial II
- University of California, San Francisco, San Francisco
RecruitingHealthy volunteers welcome
Ages 60 and older · All sexes · Updated Jun 9, 2026 · NCT03752840Strategies for Improving Linkage-to-Care After Eye Disease Screening
- University of California, San Francisco, San Francisco
Recruiting
Ages 60 and older · All sexes · Updated Apr 29, 2026 · NCT06943599Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study
- University of California, San Francisco, San Francisco
RecruitingObservational study
Ages 55 and older · All sexes · Updated Apr 29, 2026 · NCT07556406Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Loma Linda University, Loma Linda
- Eye Physicians of Long Beach, Long Beach
Recruiting
Ages 65 and older · All sexes · Updated Dec 3, 2024 · NCT05438732From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.